Prestige Wealth Management Group LLC Supernus Pharmaceuticals, Inc. Transaction History

Prestige Wealth Management Group LLC

  • $443 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$24.15 - $31.45 $2,415 - $3,145
-100 Closed
0 $0
Q4 2020

Feb 17, 2021
SELL
$17.7 - $25.81 $1,770 - $2,581
-100 Reduced 50.0%
100 $3,000
Q1 2020

May 15, 2020
BUY
$14.45 - $24.69 $1,445 - $2,469
100 Added 100.0%
200 $4,000
Q2 2019

Aug 16, 2019
BUY
$29.96 - $38.87 $2,996 - $3,886
100 New
100 $3,000

Others Institutions Holding SUPN

# of Institutions
260
Shares Held
57.3M
Call Options Held
84.1K
Put Options Held
61.2K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.39B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email